OBJECTIVE: Multiple pregnancy is associated with an increased incidence of preeclampsia. However, whether multiple pregnancy itself is also associated with hypertension later in life is unknown. This study aimed to determine whether multiple pregnancy is associated with hypertension beyond the peripartum period. STUDY DESIGN: In this retrospective nationwide population-based cohort study, we identified all women who delivered a baby between January 1, 2007 and December 31, 2008. We then tracked whether hypertension occurred during follow-up through December 31, 2015 using International Classification of Diseases-10th Revision (ICD-10) codes.
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Cox proportional hazard regressions were used to estimate the hazard ratios and 95% confidence intervals (CIs) for the association between multiple pregnancy and the development hypertension. RESULTS: Among 882,023 women who gave birth during the study period, 12,201 (1.38%) women were multiple pregnancy. The cumulative incidence of hypertension in women with multiple pregnancy was higher than those with singleton pregnancy (7.5 % vs 4.9%, respectively, p<0.01). On the Cox proportional hazards models, the risk of hypertension in women with multiple pregnancy was higher compared with those with singleton pregnancy (HR 1.21, 95% CI 1.12e1.30) after adjustment for age, primiparity, cesarean section and preeclampsia. CONCLUSION: Multiple pregnancy itself is associated with an increased risk of hypertension later in life. Therefore, guidelines for the management of these high-risk patients should be established.
440 Low cortisol to cortisone ratio precedes preeclampsia (PE) and fetal growth restriction (FGR) OBJECTIVE: To analyze the relationship between maternal serum cortisol to cortisone ratio at different stages of pregnancy and the risk of PE or FGR, given that previous studies have reported lower placental 11b-HSD2 activity in PE.
STUDY DESIGN:
We utilized a case-cohort design from the Pregnancy Outcome Prediction (POP) study including women experiencing PE (n¼194), FGR without PE (n¼185) and non-cases from a random sample of the cohort (n¼325). We measured cortisol and cortisone in maternal serum collected at w12, w20, w28 and w36 weeks of gestational age (wkGA). Associations were analyzed using logistic regression and outcomes were subdivided by preterm (<37 wkGA) or term delivery. RESULTS: A low cortisol to cortisone ratio was associated with a higher risk of PE and preterm FGR (Figure 1) . At 28wkGA, the cortisol to cortisone ratio was negatively associated (odds ratio for a 1 SD increase, 95% CI) with the risk of preterm PE (OR 0.33, 95% CI 0.19-0.57), term PE (OR 0.61, 95% CI 0.49-0.76) and preterm FGR (OR 0.50, 95% CI 0.29-0.85). At 36wkGA, the cortisol to cortisone ratio was negatively associated with term PE (OR 0.42, 95% CI 0.32-0.55) but not term FGR (OR 1.07, 95% CI 0.87-1.31). Associations were explained by both lower cortisol and higher cortisone. The associations were not materially affected by adjustment for maternal characteristics. There were no statistically significant associations with the ratio measured at w12wkGA or w20wkGA. CONCLUSION: A lower maternal serum cortisol to cortisone ratio precedes preterm delivery with PE or FGR and term delivery with PE. This finding is paradoxical given previous reports of lower placental 11b-HSD2 activity in these conditions, as the enzyme converts cortisol to cortisone. The association could be explained by either enhanced maternal 11b-HSD2 activity (e.g. renal) or reduced 11b-HSD1 activity (converts cortisone to cortisol). 
